Vendor, Framingham, MA
Kephera Diagnostics LLC
UEI LJFNSE6NM648, CAGE 7RVB8
3 awards and $600,000 obligated between September 3, 2024 and May 1, 2025, 67% under full and open competition, against 3.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 2 |
| Full and Open Competition | 1 |
| Small Business Set Aside - Total | 2 |
| Definitive Contract | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00045Definitive Contract, September 3, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | SBIR 133 - KepheraNAICS 541715, PSC AN11 | $300,000 |
| 75N93025C00003Definitive Contract, December 3, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Novel Diagnostic Biomarkers Discovery and Validation for Malaria and Select Neglected Tropical Diseases SBIR Phase INAICS 541714, PSC AN12 | $300,000 |
| 75N91021C00047Definitive Contract, September 5, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Topic 388: in Vitro Diagnostic for the Liver Flukes Opisthorchis Viverrini and Clonorchis SinensiNAICS 541715, PSC AN13 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic ResearchAN12 Health R&D Services; Health Care Services; Applied ResearchAN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 6 across 3 awards